These novel therapies , Semaglutide , represent a groundbreaking advancement in treating type 2 diabetes and potentially related conditions . These drugs are categorized as GLP-1 hormone activators , meaning these substances to mimic the natural GLP-1 substance , enhancing insulin release and lowering hunger . Although Semaglutide each operates som